These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1793783)

  • 1. Quinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole.
    Ching MS; Elliott SL; Stead CK; Murdoch RT; Devenish-Meares S; Morgan DJ; Smallwood RA
    Aliment Pharmacol Ther; 1991 Oct; 5(5):523-31. PubMed ID: 1793783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
    Wooding-Scott RA; Smalley J; Visco J; Slaughter RL
    Br J Clin Pharmacol; 1988 Oct; 26(4):415-21. PubMed ID: 3190991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers.
    Min DI; Ku YM; Geraets DR; Lee H
    J Clin Pharmacol; 1996 May; 36(5):469-76. PubMed ID: 8739026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.
    Kharasch ED; Hoffer C; Whittington D
    Br J Clin Pharmacol; 2004 May; 57(5):600-10. PubMed ID: 15089813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics.
    de Hoon JN; Thijssen HH; Beysens AJ; Van Bortel LM
    Br J Clin Pharmacol; 1997 Oct; 44(4):399-401. PubMed ID: 9354316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
    Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinidine pharmacodynamics in patients with arrhythmia: effects of left ventricular function.
    Gillis AM; Mitchell LB; Wyse DG; McDonald M; Duff HJ
    J Am Coll Cardiol; 1995 Apr; 25(5):989-94. PubMed ID: 7897143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine.
    Hardy BG; Zador IT; Golden L; Lalka D; Schentag JJ
    Am J Cardiol; 1983 Jul; 52(1):172-5. PubMed ID: 6858908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.
    Kharasch ED; Hoffer C; Altuntas TG; Whittington D
    J Clin Pharmacol; 2004 Mar; 44(3):224-33. PubMed ID: 14973303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
    Allen A; Vousden M; Lewis A
    Chemotherapy; 1999; 45(6):496-503. PubMed ID: 10567781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine interaction with nifedipine and felodipine: pharmacokinetic and pharmacodynamic evaluation.
    Bailey DG; Freeman DJ; Melendez LJ; Kreeft JH; Edgar B; Carruthers SG
    Clin Pharmacol Ther; 1993 Mar; 53(3):354-9. PubMed ID: 8453855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
    de Mey C; Enterling D; Brendel E; Wesche H
    Eur J Clin Pharmacol; 1988; 34(4):415-8. PubMed ID: 3402527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral omeprazole on the disposition of lignocaine.
    Noble DW; Bannister J; Lamont M; Andersson T; Scott DB
    Anaesthesia; 1994 Jun; 49(6):497-500. PubMed ID: 8017592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
    Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
    J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers.
    Munafo A; Buclin T; Tuto D; Biollaz J
    Eur J Clin Pharmacol; 1992; 43(4):441-3. PubMed ID: 1451729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
    Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD
    J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.